Diary - News
All news Biom’up announces first sales of HEMOBLASTTM Bellows in the United States
Saint-Priest, France, July 3, 2018 – Biom’up (the “Company”), specialist of surgical hemostasis, announces today its first commercial results in the North American market, early proof points of the strength of its US sales infrastructure.
A first shipment of its flagship product HEMOBLAST Bellows from the Company’s French production site in Saint-Priest to the Company’s central logistic hub in the US in June confirmed that the supply chain is operational, reliable and fully compliant with US regulations.
